ALPMY

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Details

Daily high

$13.64

Daily low

$13.27

Price at open

$13.42

52 Week High

$13.92

52 Week Low

$8.37

Market cap

24.1B

Dividend yield

5.63%

Volume

60,257

Avg. volume

124,586

P/E ratio

27.93

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News